AGI-1067, a novel antioxidant and anti-inflammatory agent, enhances insulin release and protects mouse islets

The antioxidant and anti-inflammatory compound AGI-1067 (succinobucol) has potential as an oral anti-diabetic agent. AGI-1067 reduces H(b)A1c, improves fasting plasma glucose, and reduces new-onset diabetes. We investigated AGI-1067 for possible effects on mouse pancreatic islets in vitro. Pretreatm...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Crim, William S., Wu, Runpei, Carter, Jeffrey D., Cole, Banumathi K., Trace, Anthony P., Mirmira, Raghavendra G., Kunsch, Charles, Nadler, Jerry L., Nunemaker, Craig S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875300/
https://ncbi.nlm.nih.gov/pubmed/20211684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2010.02.041
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller